Archive for March 31st, 2012

AVII data due Monday. RPTP ISIS NDA filings. TELK reverse split + ONTY XOMA EXEL RIGL CYCC CUR DEPO STEM IMGN news

Mar 31, 2012 No Comments by

AVI BioPharma, Inc. (NASDAQ: AVII) announced it will hold a conference call at 8:00 a.m. EDT (5:00 a.m. PDT) on Monday, April 2, 2012 to discuss top-line results from its Phase 2b study evaluating eteplirsen for the treatment of Duchenne Muscular Dystrophy (DMD). Raptor Pharmaceutical Corp.  (Nasdaq:RPTP) submitted its New Drug Application (NDA) seeking approval […]

Daily News Read more